General Meeting second convocation
AMOEBA announces the second convocation of its General Meeting
Chassieu (France), May 27, 2021 -5.45 pm- AMOÉBA (FR0011051598 – ALMIB), producer of a biological biocide capable of eliminating bacterial risk in water and human wounds, and a biocontrol product for plant protection, still in a development phase, informs that the Ordinary and Extraordinary General Meeting held today at 9:00 a.m., at the Company’s registered office, could not be held due to a lack of quorum for both ordinary and extraordinary resolutions.
Consequently, and in accordance with the legal provisions, the shareholders of the Company are hereby notified of the holding of an Ordinary and Extraordinary General Meeting convened on second call on Thursday 24 June 2021 at 9 a.m. at the Company’s registered office, 38 avenue des Frères Montgolfier – 69680 Chassieu.
In accordance with the provisions of Articles R. 225-77 and R. 225-79 of the French Commercial Code, postal voting forms sent to the Company and proxies given for the Combined General Meeting of 27 May 2021 on the first notice of meeting shall remain valid for the Ordinary and Extraordinary General Meeting convened on the second notice of meeting on the same agenda, provided that the shares are still registered.
The notice of the second convocation including the agenda will be published in the next few days in the Bulletin des Annonces Légales Obligatoires (BALO) and published on the Company’s website.
In the context of the coronavirus epidemic (COVID-19), the procedures for holding the Shareholders’ Meeting may change depending on health and/or legal requirements. Shareholders are invited to regularly consult the section dedicated to the Shareholders’ Meeting on the Company’s website (https://www.amoeba-nature.com/Investors/General-assembly).